Found 6 matching trials
Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) N/A The purpose of this program is to provide access to \[Lu-177\]-PNT2002 to p...
Show More Status
Temporarily Not Available
Location
Hoag Memorial Hospital Presbyterian
Learn More & Join Trial
PSMA Therapy and Immunotherapy in Kidney Cancer PHASE1 This is a multi-center, single arm open label phase 1b/2 study of pembroliz...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment PHASE3 The purpose of this study is to evaluate the efficacy and safety of \[Lu-17...
Show More Status
Active Not Recruiting
Location
Arizona Institute of Urology (AIU) - Tucson
Learn More & Join Trial
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study PHASE2 This phase II trial tests whether 177-Lutetium-PSMA given before stereotact...
Show More Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Radioligand fOr locAl raDiorecurrent proStaTe cancER PHASE1 Approximately 50-60% of men undergoing salvage brachytherapy post cancer re...
Show More Location
London Health Sciences Centre
Learn More & Join Trial
177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma PHASE2 This is a single arm trial with one Cohort for people with recurrent or met...
Show More Location
Johns Hopkins Hospital
Learn More & Join Trial